Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IBD

IBD risk prediction using multi-ethnic polygenic risk scores

Nature Reviews Gastroenterology & Hepatology volume 18, pages 217–218 (2021)Cite this article

Subjects

Inflammatory bowel disease (IBD) has emerged as a global disease, yet identifying those at higher risk of developing IBD remains challenging. A new study highlights the use of a multi-ethnic polygenic risk score to determine risk of inflammatory bowel disease in a large primary care population.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hugot, J. P., Chamaillard, M. & Zouali, H. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603 (2001).

    Article  CAS  Google Scholar 

  2. Liu, J. Z., van Sommeren, S. & Huang, H. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).

    Article  CAS  Google Scholar 

  3. Huang, H., Fang, M. & Jostins, L. et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547, 173–178 (2017).

    Article  CAS  Google Scholar 

  4. Beaudoin, M., Goyette, P. & Boucher, G. et al. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet. 9, e1003723 (2013).

    Article  CAS  Google Scholar 

  5. Rivas, M. A., Graham, D. & Sulem, P. et al. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat. Commun. 7, 12342 (2016).

    Article  CAS  Google Scholar 

  6. Brant, S. R., Okou, D. T. & Simpson, C. L. et al. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology 152, 206–217 e2 (2017).

    Article  CAS  Google Scholar 

  7. Gettler, K. et al. Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort. Gastroenterology https://doi.org/10.1053/j.gastro.2020.12.034 (2020).

    Article  PubMed  Google Scholar 

  8. Tai, Y., Wang, Q. & Korner, H. et al. Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases. Front. Pharmacol. 9, 642 (2018).

    Article  Google Scholar 

  9. Torres, J., Hu, J. & Seki, A. et al. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut 69, 42–51 (2020).

    Article  CAS  Google Scholar 

  10. Torres, J., Petralia, F. & Sato, T. et al. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis. Gastroenterology 159, 96–104 (2020).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

A.N.A. is supported by grants from the National Institutes of Health, Crohn’s and Colitis foundation, and the Chleck Family Foundation.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA

    Ashwin N. Ananthakrishnan

  2. Harvard Medical School, Boston, MA, USA

    Ashwin N. Ananthakrishnan

Authors
  1. Ashwin N. Ananthakrishnan
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Ashwin N. Ananthakrishnan.

Ethics declarations

Competing interests

A.N.A. has served on the scientific advisory board of Kyn Therapeutics, Sun Pharma and Gilead.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ananthakrishnan, A.N. IBD risk prediction using multi-ethnic polygenic risk scores. Nat Rev Gastroenterol Hepatol 18, 217–218 (2021). https://doi.org/10.1038/s41575-021-00425-5

Download citation

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41575-021-00425-5

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing